Health Care & Life Sciences » Biotechnology | Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,503.00
8,541.00
15,955.00
9,990.00
7,756.00
7,064
Total Accounts Receivable
910.00
1,005.00
759.00
306.00
672.00
2,009
Other Current Assets
33.00
32.00
74.00
148.00
1,195.00
1,197
Total Current Assets
4,446.00
9,578.00
16,788.00
10,444.00
9,623.00
10,270
Net Property, Plant & Equipment
258.00
313.00
271.00
297.00
392.00
651
Other Assets
22.00
20.00
21.00
25.00
1,408.00
307
Total Assets
4,726.00
9,911.00
17,080.00
10,766.00
11,423.00
11,228
Accounts Payable
228.00
-
-
-
-
Other Current Liabilities
1,104.00
3,113.00
2,952.00
864.00
5,543.00
Total Current Liabilities
1,332.00
3,113.00
2,952.00
864.00
5,543.00
Other Liabilities
655.00
123.00
-
-
-
Total Liabilities
1,987.00
3,236.00
2,952.00
864.00
5,543.00
Common Equity (Total)
2,739.00
6,675.00
14,128.00
9,902.00
5,880.00
Total Shareholders' Equity
2,739.00
6,675.00
14,128.00
9,902.00
5,880.00
Total Equity
2,739.00
6,675.00
14,128.00
9,902.00
5,880.00
Liabilities & Shareholders' Equity
4,726.00
9,911.00
17,080.00
10,766.00
11,423.00

About Brainstorm Cell Therapeutics

View Profile
Address
1325 Avenue of Americas
New York New Jersey 10019
United States
Employees -
Website http://www.brainstorm-cell.com
Updated 07/08/2019
Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NJ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.